| Item Type | Name |
|
Academic Article
|
Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients.
|
|
Academic Article
|
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|
|
Academic Article
|
Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease.
|
|
Academic Article
|
Expression of Bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid.
|
|
Academic Article
|
Adenovirus infections in adult recipients of blood and marrow transplants.
|
|
Academic Article
|
High CD34 cell doses do not worsen regimen-related toxicity or early mortality after autologous blood stem cell transplantation for breast cancer.
|
|
Academic Article
|
166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials.
|
|
Academic Article
|
Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation.
|
|
Academic Article
|
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma.
|
|
Academic Article
|
Resolved hepatitis B virus infection is not associated with worse outcome after allogeneic hematopoietic stem cell transplantation.
|
|
Academic Article
|
High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-cell transplantation in patients with refractory lymphoid malignancies.
|
|
Academic Article
|
Results of a retrospective single institution analysis of targeted skeletal radiotherapy with (166)Holmium-DOTMP as conditioning regimen for autologous stem cell transplant for patients with multiple myeloma. Impact on transplant outcomes.
|
|
Academic Article
|
Infections in 100 cord blood transplantations: spectrum of early and late posttransplant infections in adult and pediatric patients 1996-2005.
|
|
Academic Article
|
Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial.
|
|
Academic Article
|
PET imaging of T cells derived from umbilical cord blood.
|
|
Academic Article
|
Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
|
|
Academic Article
|
The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomes.
|
|
Academic Article
|
Lymphocyte recovery predicts outcomes in cord blood and T cell-depleted haploidentical stem cell transplantation.
|
|
Academic Article
|
Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.
|
|
Academic Article
|
Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60-78 years of age.
|
|
Academic Article
|
Autologous stem cell transplantation for refractory or poor-risk relapsed Hodgkin's lymphoma: effect of the specific high-dose chemotherapy regimen on outcome.
|
|
Academic Article
|
Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies.
|
|
Academic Article
|
Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation.
|
|
Academic Article
|
Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients.
|
|
Academic Article
|
Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma.
|
|
Academic Article
|
A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts.
|
|
Academic Article
|
Clofarabine ? fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS.
|
|
Concept
|
Survival Rate
|
|
Concept
|
Disease-Free Survival
|
|
Concept
|
Survival Analysis
|
|
Concept
|
Cell Survival
|
|
Concept
|
Graft Survival
|
|
Academic Article
|
Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years.
|
|
Academic Article
|
Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease.
|
|
Academic Article
|
Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT.
|
|
Academic Article
|
Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome.
|
|
Academic Article
|
Hematopoietic progenitor cell collection in patients with chronic myelogenous leukemia in complete cytogenetic remission after imatinib mesylate therapy.
|
|
Academic Article
|
Outcomes of patients with myeloid malignancies treated with allogeneic hematopoietic stem cell transplantation from matched unrelated donors compared with one human leukocyte antigen mismatched related donors using HLA typing at 10 loci.
|
|
Academic Article
|
Unrelated donor transplantation for acute myelogenous leukemia in first remission.
|
|
Academic Article
|
Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively randomized study.
|
|
Academic Article
|
Feasibility of autologous hematopoietic stem cell transplant in patients aged =70 years with multiple myeloma.
|
|
Academic Article
|
Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma.
|
|
Academic Article
|
Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections.
|
|
Academic Article
|
Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial.
|
|
Academic Article
|
Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors.
|
|
Academic Article
|
Allogeneic bone marrow transplants for Fanconi anemia. A preliminary report from the International Bone Marrow Transplant Registry.
|
|
Academic Article
|
Improved survival following bone marrow transplantation for aplastic anaemia.
|
|
Academic Article
|
Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.
|
|
Academic Article
|
Effect of induction cytarabine dose intensity on long-term survival in acute myelogenous leukemia: results of a randomized, controlled study.
|
|
Academic Article
|
Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients.
|
|
Academic Article
|
Selective depletion of CD8+ cells for prevention of graft-versus-host disease after bone marrow transplantation. A randomized controlled trial.
|
|
Academic Article
|
Results with high-dose chemotherapy and unpurged autologous stem cell transplantation in 73 patients with chronic myelogenous leukemia: the MD Anderson experience.
|
|
Academic Article
|
Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients.
|
|
Academic Article
|
Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer.
|
|
Academic Article
|
Prognostic value of cytogenetics in multiple myeloma.
|
|
Academic Article
|
Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma.
|
|
Academic Article
|
Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma.
|
|
Academic Article
|
Allogeneic haematopoietic transplantation for Richter's syndrome.
|
|
Academic Article
|
Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen-matched related donors.
|
|
Academic Article
|
Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I study.
|
|
Academic Article
|
Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase II study.
|
|
Academic Article
|
Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
|
|
Academic Article
|
Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma.
|
|
Academic Article
|
Treatment of relapsing refractory diffuse large cell lymphoma after matched unrelated donor bone marrow transplant with immunosuppression withdrawal and rituximab.
|
|
Academic Article
|
Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphoma.
|
|
Academic Article
|
Comparison of 100-day mortality rates associated with i.v. busulfan and cyclophosphamide vs other preparative regimens in allogeneic bone marrow transplantation for chronic myelogenous leukemia: Bayesian sensitivity analyses of confounded treatment and center effects.
|
|
Academic Article
|
Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation.
|
|
Academic Article
|
Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.
|
|
Academic Article
|
Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
|
|
Academic Article
|
Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS).
|
|
Academic Article
|
Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma.
|
|
Academic Article
|
Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome.
|
|
Academic Article
|
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.
|
|
Academic Article
|
Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.
|
|
Academic Article
|
Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML.
|
|
Academic Article
|
Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma.
|
|
Academic Article
|
Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer.
|
|
Academic Article
|
Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic leukemia: long-term follow-up, prognostic factors, and effect of human leukocyte histocompatibility antigen subtype on outcome.
|
|
Academic Article
|
Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes.
|
|
Academic Article
|
Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL.
|
|
Academic Article
|
Dose intensification of busulfan in the preparative regimen is associated with improved survival: a phase I/II controlled, randomized study.
|
|
Academic Article
|
Selective depletion of CD8-positive T-lymphocytes for allogeneic bone marrow transplantation: engraftment, graft-versus-host disease and graft-versus leukemia.
|
|
Academic Article
|
Second HLA-identical sibling transplants for leukemia recurrence.
|
|
Academic Article
|
The use of GM-CSF as an adjunct to autologous/syngeneic bone marrow transplantation: a prospective randomized controlled trial.
|
|
Academic Article
|
T-cell depletion for bone marrow transplantation: effects on graft rejection, graft-versus-host disease, graft-versus-leukemia, and survival.
|
|
Academic Article
|
Bone marrow transplantation for severe aplastic anemia. Effect of a preparative regimen of cyclophosphamide-low-dose total-lymphoid irradiation and posttransplant cyclosporine-methotrexate therapy.
|
|
Academic Article
|
Survival and immune recovery in dogs following fetal liver transplantation.
|
|
Academic Article
|
Prolonged survival in acute myelogenous leukaemia without maintenance chemotherapy.
|
|
Academic Article
|
Infectious complications of bone marrow transplantation.
|
|
Academic Article
|
A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for autologous transplantation for malignant lymphoma.
|
|
Academic Article
|
High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity.
|
|
Academic Article
|
Bone marrow transplantation for Fanconi anemia.
|
|
Academic Article
|
Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management.
|
|
Academic Article
|
Benefit of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia.
|
|
Academic Article
|
T-cell depletion for allogeneic bone marrow transplantation: impact on graft-versus-host disease, engraftment, and graft-versus-leukemia.
|
|
Academic Article
|
Identical-twin bone marrow transplants for leukemia.
|
|
Academic Article
|
B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny?
|
|
Academic Article
|
Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial.
|
|
Academic Article
|
Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program.
|
|
Academic Article
|
Chemotherapy versus transplants for acute myelogenous leukemia in second remission.
|
|
Academic Article
|
GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation.
|
|
Academic Article
|
Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir.
|
|
Academic Article
|
High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome.
|
|
Academic Article
|
Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.
|
|
Academic Article
|
Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer.
|
|
Academic Article
|
High-dose chemotherapy with autologous stem cell support in patients with breast cancer.
|
|
Academic Article
|
Hematopoietic stem cell transplantation for chronic lymphocytic leukemia.
|
|
Academic Article
|
Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma.
|
|
Academic Article
|
Purging of contaminating breast cancer cells from hematopoietic stem cell grafts by adenoviral GAL-TEK gene therapy and magnetic antibody cell separation.
|
|
Academic Article
|
Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy.
|
|
Academic Article
|
Cytomegalovirus disease in adult marrow transplant recipients receiving ganciclovir prophylaxis: a retrospective study.
|
|
Academic Article
|
Graft-vs.-malignancy with allogeneic blood stem cell transplantation: a potential primary treatment modality.
|
|
Academic Article
|
Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy.
|
|
Academic Article
|
Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor program.
|
|
Academic Article
|
Status of high-dose chemotherapy for breast cancer: a review.
|
|
Academic Article
|
Preemptive control of graft-versus-host disease in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes.
|
|
Academic Article
|
High-dose chemotherapy followed by stem cell transplantation in patients with resistant Waldenstrom's macroglobulinemia.
|
|
Academic Article
|
Impact of complete remission with intensive therapy in patients with responsive multiple myeloma.
|
|
Academic Article
|
Long-Term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation.
|
|
Academic Article
|
Community respiratory virus infections in bone marrow transplant recipients: the M.D. Anderson Cancer Center experience.
|
|
Academic Article
|
Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.
|
|
Academic Article
|
High-dose chemotherapy with hematopoietic stem-cell transplantation for breast cancer: current status, future trends.
|
|
Academic Article
|
Factors affecting progression-free survival in hormone-dependent metastatic breast cancer patients receiving high-dose chemotherapy and hematopoietic progenitor cell transplantation: role of maintenance endocrine therapy.
|
|
Academic Article
|
Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemia.
|
|
Academic Article
|
Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphoma.
|
|
Academic Article
|
Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival.
|
|
Academic Article
|
Nonmyeloablative stem cell transplantation for lymphoma.
|
|
Academic Article
|
Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.
|
|
Academic Article
|
Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma.
|
|
Academic Article
|
Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation.
|
|
Academic Article
|
The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy.
|
|
Academic Article
|
Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.
|
|
Academic Article
|
Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.
|
|
Academic Article
|
Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia.
|
|
Academic Article
|
Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?
|
|
Academic Article
|
Second autologous or allogeneic transplantation after the failure of first autograft in patients with multiple myeloma.
|
|
Academic Article
|
High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapy.
|
|
Academic Article
|
Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation.
|
|
Academic Article
|
Risk factors for relapse after complete remission with high-dose therapy for multiple myeloma.
|
|
Academic Article
|
Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia.
|
|
Academic Article
|
Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence.
|
|
Academic Article
|
Natural history of metastatic renal cell carcinoma in patients who underwent consultation for allogeneic hematopoietic stem cell transplantation.
|
|
Academic Article
|
Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysis.
|
|
Academic Article
|
Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome.
|
|
Academic Article
|
Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation.
|
|
Academic Article
|
The outcome of IgD myeloma after autologous hematopoietic stem cell transplantation is similar to other Ig subtypes.
|
|
Academic Article
|
Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia.
|
|
Academic Article
|
A randomized phase 2 trial of a preparative regimen of bortezomib, high-dose melphalan, arsenic trioxide, and ascorbic acid.
|
|
Academic Article
|
Randomized phase II trial comparing two dose levels of thymoglobulin in patients undergoing unrelated donor hematopoietic cell transplant.
|
|
Academic Article
|
Durable remission with salvage second autotransplants in patients with multiple myeloma.
|
|
Academic Article
|
Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience.
|
|
Academic Article
|
Fifty years of melphalan use in hematopoietic stem cell?transplantation.
|
|
Academic Article
|
Nonmyeloablative allogeneic stem cell transplantation for non-hodgkin lymphoma.
|
|
Academic Article
|
Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: a retrospective case-control study.
|
|
Academic Article
|
Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia.
|
|
Academic Article
|
Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission.
|
|
Academic Article
|
Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia.
|
|
Academic Article
|
Bone marrow transplantation using unrelated donors for patients with advanced leukemia or bone marrow failure.
|
|
Academic Article
|
Immune thrombocytopenia in dogs after fetal liver hematopoietic cell transplantation.
|
|
Academic Article
|
Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effect.
|
|
Academic Article
|
Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donors.
|
|
Academic Article
|
Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantation.
|
|
Academic Article
|
Early myeloablative therapy for multiple myeloma.
|
|
Academic Article
|
Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for marrow transplantation: risk factors for early regimen-related toxicity.
|
|
Academic Article
|
Use of cytosine arabinoside and total body irradiation as conditioning for allogeneic marrow transplantation in patients with acute lymphoblastic leukemia: a multicenter survey.
|
|
Academic Article
|
Effect of prior interferon alfa therapy on the outcome of allogeneic bone marrow transplantation for chronic myelogenous leukemia.
|
|
Academic Article
|
Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.
|
|
Academic Article
|
Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease.
|
|
Academic Article
|
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation.
|
|
Academic Article
|
Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus.
|
|
Academic Article
|
Allogeneic blood stem cell transplantation in advanced hematologic cancers.
|
|
Academic Article
|
A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation.
|
|
Academic Article
|
Hematopoietic retroviral gene marking in patients with follicular non-Hodgkin's lymphoma.
|
|
Academic Article
|
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation.
|
|
Academic Article
|
Allogeneic transplantation for low-grade lymphoma: long-term follow-up.
|
|
Academic Article
|
Importance of radiation therapy for breast cancer patients treated with high-dose chemotherapy and stem cell transplant.
|
|
Academic Article
|
A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation.
|
|
Academic Article
|
Mini-allografts: ongoing trials in humans.
|
|
Academic Article
|
Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.
|
|
Academic Article
|
T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities.
|
|
Academic Article
|
Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy).
|
|
Academic Article
|
Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: non-myeloablative preparative regimens and induction of the graft-versus-leukemia effect.
|
|
Academic Article
|
Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation.
|
|
Academic Article
|
Expression of a truncated first exon BCR sequence in chronic myelogenous leukemia cells blocks cell growth and induces cell death.
|
|
Academic Article
|
Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival.
|
|
Academic Article
|
High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of advanced ovarian cancer.
|
|
Academic Article
|
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality.
|
|
Academic Article
|
Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity.
|
|
Academic Article
|
HER-2/neu overexpression as a poor prognostic factor for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous stem cell transplantation.
|
|
Academic Article
|
Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality.
|
|
Academic Article
|
Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias.
|
|
Academic Article
|
Predicting outcome based on Swenerton score in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation: implications for patient selection.
|
|
Academic Article
|
Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate.
|
|
Academic Article
|
Long-term follow-up of autologous stem cell transplantation in patients with diffuse mantle cell lymphoma in first disease remission: the prognostic value of beta2-microglobulin and the tumor score.
|
|
Academic Article
|
Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantation.
|
|
Academic Article
|
High-dose topotecan, melphalan and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of multiple myeloma.
|
|
Academic Article
|
Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma.
|
|
Academic Article
|
Comparison of high-dose melphalan with a more intensive regimen of thiotepa, busulfan, and cyclophosphamide for patients with multiple myeloma.
|
|
Academic Article
|
Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas.
|
|
Academic Article
|
Survival benefit with imatinib mesylate therapy in patients with accelerated-phase chronic myelogenous leukemia--comparison with historic experience.
|
|
Academic Article
|
Total body irradiation, fludarabine, melphalan, and allogeneic hematopoietic stem cell transplantation for advanced pediatric hematologic malignancies.
|
|
Academic Article
|
Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: follow-up at 12 years.
|
|
Academic Article
|
Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia.
|
|
Academic Article
|
Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocytic leukaemia.
|
|
Academic Article
|
Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation.
|
|
Academic Article
|
Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.
|
|
Academic Article
|
Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment.
|
|
Academic Article
|
Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer.
|
|
Academic Article
|
Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma.
|
|
Academic Article
|
Quantifying the survival benefit for allogeneic hematopoietic stem cell transplantation in relapsed acute myelogenous leukemia.
|
|
Academic Article
|
First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia.
|
|
Academic Article
|
Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding study.
|
|
Academic Article
|
Fludarabine, cyclophosphamide, and antithymocyte globulin for matched related and unrelated allogeneic stem cell transplant in severe aplastic anemia.
|
|
Academic Article
|
Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life.
|
|
Academic Article
|
Prognostic value of response after upfront therapy for acute GVHD.
|
|
Academic Article
|
Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
|
|
Academic Article
|
Platelet recovery before allogeneic stem cell transplantation predicts posttransplantation outcomes in patients with acute myelogenous leukemia and myelodysplastic syndrome.
|
|
Academic Article
|
Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of tyrosine kinase inhibitors on treatment outcomes.
|
|
Academic Article
|
Allogeneic stem cell transplantation for chronic myeloid leukemia resistant to tyrosine kinase inhibitors.
|
|
Academic Article
|
Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study.
|
|
Academic Article
|
Significance of persistent cytogenetic abnormalities on myeloablative allogeneic stem cell transplantation in first complete remission.
|
|
Academic Article
|
Tacrolimus-associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation.
|
|
Academic Article
|
Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission.
|
|
Academic Article
|
High-dose chemotherapy and autologous stem cell transplantation for nodular lymphocyte-predominant Hodgkin lymphoma.
|
|
Academic Article
|
Outcomes of adults with acute lymphoblastic leukemia relapsing after allogeneic hematopoietic stem cell transplantation.
|
|
Academic Article
|
Cytarabine, Ki-67, and SOX11 in patients with mantle cell lymphoma receiving rituximab-containing autologous stem cell transplantation during first remission.
|
|
Academic Article
|
Hematopoietic cell transplantation-specific comorbidity index predicts inpatient mortality and survival in patients who received allogeneic transplantation admitted to the intensive care unit.
|
|
Academic Article
|
Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy.
|
|
Academic Article
|
Postremission chemotherapy for adults with acute myelogenous leukemia: improved survival with high-dose cytarabine and daunorubicin consolidation treatment.
|
|
Academic Article
|
Bone marrow transplantation from HLA-matched unrelated donors as treatment for leukemia.
|
|
Academic Article
|
Refractory chronic lymphocytic leukemia complicated by hypercalcemia treated with allogeneic bone marrow transplantation. Case report and review.
|
|
Academic Article
|
Impact of preexisting CNS involvement on the outcome of bone marrow transplantation in adult hematologic malignancies.
|
|
Academic Article
|
Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue.
|
|
Academic Article
|
Bone marrow transplantation for severe aplastic anemia: has outcome improved?
|
|
Academic Article
|
Survival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplantation: comparison with patients receiving conventional chemotherapy.
|
|
Academic Article
|
Outcome of bone marrow transplantation patients requiring mechanical ventilation.
|
|
Academic Article
|
Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).
|
|
Academic Article
|
Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimens.
|
|
Academic Article
|
Phase II study of autologous transplantation with interleukin-2-incubated peripheral blood stem cells and posttransplantation interleukin-2 in relapsed or refractory non-Hodgkin lymphoma.
|
|
Academic Article
|
Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens.
|
|
Academic Article
|
Control of graft-versus-host disease with maintenance of the graft-versus-leukemia effect in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes.
|
|
Academic Article
|
Fifth Annual International Umbilical Cord Blood Transplantation Symposium, Los Angeles, California, May 11-12, 2007.
|
|
Academic Article
|
Allogeneic hematopoietic cell transplantation for metastatic breast cancer.
|
|
Academic Article
|
Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience.
|
|
Academic Article
|
The natural history and treatment outcome of blast phase BCR-ABL- myeloproliferative neoplasms.
|
|
Academic Article
|
Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial.
|
|
Academic Article
|
Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes.
|
|
Academic Article
|
Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fraction.
|
|
Academic Article
|
Phase II trial of high-dose topotecan, melphalan and CY with autologous stem cell support for multiple myeloma.
|
|
Academic Article
|
Fludarabine, melphalan, thiotepa and anti-thymocyte globulin conditioning for unrelated cord blood transplant.
|
|
Academic Article
|
Durable responses after donor lymphocyte infusion for patients with residual multiple myeloma following non-myeloablative allogeneic stem cell transplant.
|
|
Academic Article
|
Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapy.
|
|
Academic Article
|
Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation.
|
|
Academic Article
|
Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome.
|
|
Academic Article
|
Transplantation of DLA-compatible and incompatible fetal liver hematopoietic cells in dogs.
|
|
Academic Article
|
A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic marrow transplantation.
|
|
Academic Article
|
Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies.
|
|
Academic Article
|
Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS.
|
|
Academic Article
|
Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure.
|
|
Academic Article
|
Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation.
|
|
Academic Article
|
Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies.
|
|
Academic Article
|
Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation.
|
|
Academic Article
|
Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia.
|
|
Academic Article
|
Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation.
|
|
Academic Article
|
Intravenous busulfan plus melphalan is a highly effective, well-tolerated preparative regimen for autologous stem cell transplantation in patients with advanced lymphoid malignancies.
|
|
Academic Article
|
Tyrosine kinase inhibitors as initial therapy for patients with chronic myeloid leukemia in accelerated phase.
|
|
Academic Article
|
Durable responses with autologous hematopoietic SCT in patients with POEMS syndrome.
|
|
Academic Article
|
Increasing chimerism after allogeneic stem cell transplantation is associated with longer survival time.
|
|
Academic Article
|
Short-term cardiac toxicity of autologous hematopoietic stem cell transplant for multiple myeloma.
|
|
Academic Article
|
Auto-SCT improves survival in systemic light chain amyloidosis: a retrospective analysis with 14-year follow-up.
|
|
Academic Article
|
Allogeneic stem cell transplant in patients with chronic lymphocytic leukemia with 17p deletion: consult-transplant versus consult- no-transplant analysis.
|
|
Academic Article
|
Cytogenetics, donor type, and use of hypomethylating agents in myelodysplastic syndrome with allogeneic stem cell transplantation.
|
|
Academic Article
|
Characteristics and outcomes of patients with multiple myeloma who develop therapy-related myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia.
|
|
Academic Article
|
Long-term survival after transplantation of unrelated donor peripheral blood or bone marrow hematopoietic cells for hematologic malignancy.
|
|
Academic Article
|
Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation.
|
|
Academic Article
|
Can a female donor for a male recipient decrease the relapse rate for patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation?
|
|
Academic Article
|
Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts.
|
|
Academic Article
|
Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies.
|
|
Academic Article
|
High-dose therapy with auto-SCT is feasible in high-risk cardiac amyloidosis.
|
|
Academic Article
|
Age and Modified European LeukemiaNet Classification to Predict Transplant Outcomes: An Integrated Approach for Acute Myelogenous Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation.
|
|
Academic Article
|
Outcome of Patients with Immunoglobulin Light-Chain Amyloidosis with Lung, Liver, Gastrointestinal, Neurologic, and Soft Tissue Involvement after Autologous Hematopoietic Stem Cell Transplantation.
|
|
Academic Article
|
Autologous Hematopoietic Stem Cell Transplantation in Dialysis-Dependent Myeloma Patients.
|
|
Academic Article
|
Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation.
|
|
Academic Article
|
Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas.
|
|
Academic Article
|
Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of?Acute Myeloid Leukemia and Myelodysplastic Syndromes.
|
|
Academic Article
|
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors.
|
|
Academic Article
|
Better allele-level matching improves transplant-related mortality after double cord blood transplantation.
|
|
Academic Article
|
Improvement in clinical outcome of FLT3 ITD mutated acute myeloid leukemia patients over the last one and a half decade.
|
|
Academic Article
|
Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
|
|
Academic Article
|
Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for?Patients with Chronic Myelomonocytic Leukemia.
|
|
Academic Article
|
Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation.
|
|
Academic Article
|
Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution.
|
|
Academic Article
|
Romidepsin targets multiple survival signaling pathways in malignant T cells.
|
|
Academic Article
|
The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy.
|
|
Academic Article
|
Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502.
|
|
Academic Article
|
Maintenance Therapy With Immunomodulatory Drugs in Multiple Myeloma: A Meta-Analysis and Systematic Review.
|
|
Academic Article
|
Outcome of Patients With Nonsecretory Multiple Myeloma After Autologous Hematopoietic Stem Cell Transplantation.
|
|
Academic Article
|
Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation.
|
|
Academic Article
|
Outcomes of Allogeneic Hematopoietic Cell Transplantation in?Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors.
|
|
Academic Article
|
Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients.
|
|
Academic Article
|
Gemcitabine, Fludarabine, and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell?Transplantation for Relapsed and Refractory Hodgkin?Lymphoma.
|
|
Academic Article
|
Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation.
|
|
Academic Article
|
Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant.
|
|
Academic Article
|
Outcome of Patients with Multiple Myeloma and CKS1B Gene Amplification after Autologous Hematopoietic Stem Cell Transplantation.
|
|
Academic Article
|
Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
|
|
Academic Article
|
Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for High-Risk Acute Lymphoblastic Leukemia.
|
|
Academic Article
|
Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival forPatients with Chronic Myelomonocytic Leukemia
|
|
Academic Article
|
Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma
|
|
Academic Article
|
Comparable survival for nonablative and ablative allogeneic transplantation for chronic lymphocytic leukemia (CLL)
|
|
Academic Article
|
Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients
|
|
Academic Article
|
The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy
|
|
Academic Article
|
Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma.
|
|
Academic Article
|
A randomized phase II study of standard-dose versus high-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term results.
|
|
Academic Article
|
High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison with melphalan.
|
|
Academic Article
|
Autologous hematopoietic stem cell transplantation in light chain amyloidosis (AL) with renal involvement.
|
|
Academic Article
|
Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation.
|
|
Academic Article
|
Optimal Threshold and Time of Absolute Lymphocyte Count?Assessment for Outcome Prediction after Bone Marrow?Transplantation.
|
|
Academic Article
|
Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium-Haplo2014, San Francisco, California, December 4, 2014.
|
|
Academic Article
|
Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents.
|
|
Academic Article
|
Long-Term Outcomes after Treatment with Clofarabine???Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome.
|
|
Academic Article
|
Prognostic significance of day 14 bone marrow evaluation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia.
|
|
Academic Article
|
PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies.
|
|
Academic Article
|
Allogeneic Transplantation in First Remission Improves Outcomes Irrespective of FLT3-ITD Allelic Ratio in FLT3-ITD-Positive Acute Myelogenous Leukemia.
|
|
Academic Article
|
Double epigenetic modulation of high-dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor-risk relapsed lymphoma.
|
|
Academic Article
|
Stem cell transplantation outcomes in lymphoblastic lymphoma.
|
|
Academic Article
|
Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells.
|
|
Academic Article
|
Synergistic cytotoxicity of busulfan, melphalan, gemcitabine, panobinostat, and bortezomib in lymphoma cells.
|
|
Academic Article
|
Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results.
|
|
Academic Article
|
Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients.
|
|
Academic Article
|
Relapse risk and survival in patients with FLT3 mutated acute myeloid leukemia undergoing stem cell transplantation.
|
|
Academic Article
|
Prognostic Index for Critically Ill Allogeneic Transplantation Patients.
|
|
Academic Article
|
Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomes.
|
|
Academic Article
|
Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative acute lymphoblastic leukemia in the era of minimal residual disease.
|
|
Academic Article
|
Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission.
|
|
Academic Article
|
Differential impact of minimal residual disease negativity according to the salvage status in patients with relapsed/refractory B-cell acute lymphoblastic leukemia.
|
|
Academic Article
|
Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma.
|
|
Academic Article
|
Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse risk and inferior survival.
|
|
Academic Article
|
Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning.
|
|
Academic Article
|
Predictive model for survival in patients with AML/MDS receiving haploidentical stem cell transplantation.
|
|
Academic Article
|
Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors.
|
|
Academic Article
|
The PARP inhibitor olaparib enhances the cytotoxicity of combined gemcitabine, busulfan and melphalan in lymphoma cells.
|
|
Academic Article
|
Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery.
|
|
Academic Article
|
Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myeloma.
|
|
Academic Article
|
Salvage Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini-Hyper-CVD for Patients With Relapsed or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Phase 2 Clinical Trial.
|
|
Academic Article
|
Clinical outcomes in adult patients with aplastic anemia: A single institution experience.
|
|
Academic Article
|
Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma.
|
|
Academic Article
|
Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia.
|
|
Academic Article
|
Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation.
|
|
Academic Article
|
Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and the University of Texas MD Anderson Cancer Center.
|
|
Academic Article
|
Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion.
|
|
Academic Article
|
Amifostine reduces gastro-intestinal toxicity after autologous transplantation for multiple myeloma.
|
|
Academic Article
|
Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin Lymphoma.
|
|
Academic Article
|
Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit.
|
|
Academic Article
|
Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000.
|
|
Academic Article
|
CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes.
|
|
Academic Article
|
Is a matched unrelated donor search needed for all allogeneic transplant candidates?
|
|
Academic Article
|
Impact of a novel prognostic model, hematopoietic cell transplant-composite risk (HCT-CR), on allogeneic transplant outcomes in patients with acute myeloid leukemia and myelodysplastic syndrome.
|
|
Academic Article
|
Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib.
|
|
Academic Article
|
Overall survival in older patients with cancer.
|
|
Academic Article
|
Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia.
|
|
Academic Article
|
Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations.
|
|
Academic Article
|
Pulmonary Impairment after Respiratory Viral Infections Is Associated with High Mortality in Allogeneic Hematopoietic Cell Transplant Recipients.
|
|
Academic Article
|
Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs.
|
|
Academic Article
|
Long-term durable efficacy of autologous stem cell transplantation in POEMS syndrome.
|
|
Academic Article
|
Impact of Donor Type and Melphalan Dose on Allogeneic Transplantation Outcomes for Patients with Lymphoma.
|
|
Academic Article
|
Allogeneic Transplantation after Myeloablative Rituximab/BEAM ? Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results.
|
|
Academic Article
|
Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Three Different Conditioning Regimens.
|
|
Academic Article
|
Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: long-term results of a prospective phase II clinical trial.
|
|
Academic Article
|
Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning.
|
|
Academic Article
|
Outcomes of autologous stem cell transplantation in Waldenstr?m's macroglobulinemia.
|
|
Academic Article
|
Outcomes of autologous hematopoietic cell transplantation in myeloma patients aged =75 years.
|
|
Academic Article
|
Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy.
|
|
Academic Article
|
Haploidentical transplantation for acute myeloid leukemia patients with minimal/measurable residual disease at transplantation.
|
|
Academic Article
|
Age Is a Prognostic Factor for the Overall Survival of Patients with Multiple Myeloma Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation.
|
|
Academic Article
|
Validation of a Hematopoietic Cell Transplant-Composite Risk (HCT-CR) Model for Post-Transplant Survival Prediction in Patients with Hematologic Malignancies.
|
|
Academic Article
|
Posttransplantation cyclophosphamide improves transplantation outcomes in patients with AML/MDS who are treated with checkpoint inhibitors.
|
|
Academic Article
|
Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trial.
|
|
Academic Article
|
Phase I/II study of dasatinib in combination with decitabine in patients with accelerated or blast phase chronic myeloid leukemia.
|
|
Academic Article
|
Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndrome.
|
|
Academic Article
|
High levels of common cold coronavirus antibodies in convalescent plasma are associated with improved survival in COVID-19 patients.
|
|
Academic Article
|
Allogeneic stem cell transplant for patients with myeloproliferative neoplasms in blast phase: improving outcomes in the recent era.
|
|
Academic Article
|
Prognostic factors for progression in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in complete molecular response within 3 months of therapy with tyrosine kinase inhibitors.
|
|
Academic Article
|
Acute graft-versus-host disease is the foremost cause of late nonrelapse mortality.
|
|
Academic Article
|
Impact of Cell of Origin Classification on Survival Outcomes after Autologous Transplantation in Relapsed/Refractory Diffuse Large B Cell Lymphoma.
|
|
Academic Article
|
High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients.
|
|
Academic Article
|
Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation.
|
|
Academic Article
|
Decrease post-transplant relapse using donor-derived expanded NK-cells.
|
|
Academic Article
|
A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myeloma.
|
|
Academic Article
|
Black multiple myeloma patients undergoing upfront autologous stem cell transplant have similar survival outcomes compared to Whites: A propensity-score matched analysis.
|
|
Academic Article
|
Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma.
|
|
Academic Article
|
Donor selection for KIR alloreactivity is associated with superior survival in haploidentical transplant with PTCy.
|
|
Academic Article
|
Evolving trends and outcomes in older patients with acute myeloid leukemia including allogeneic stem cell transplantation.
|
|
Academic Article
|
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial.
|
|
Academic Article
|
Mycophenolate mofetil is associated with inferior overall survival in cytomegalovirus seropositive patients with acute myeloid leukemia undergoing hematopoietic cell transplantation.
|